......30 6.3. Rationale for Obtaining Archival Tissue and Performing Tumor Biopsies ............... 31 6.4. Rationale for Inclusion of Squamous Cell Carcinoma Patients ................................ ..31 6.5. Rationale for Checkpoint In hibitor Progressor Patients and First Line Maintenance Patients ................................ ................................